Status:
ACTIVE_NOT_RECRUITING
Rebreathing-induced Hypoxia and Glucose Levels
Lead Sponsor:
University of Texas at Austin
Conditions:
Hypoxemia
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The aim of this research project is to determine the effect of repeated maximal voluntary apneas on glucose uptake during an oral glucose tolerance test in healthy individuals, individuals with predia...
Detailed Description
It is predicted that 1 in 3 adults will develop diabetes by 2050, implying that a large percentage of the population will become at high risk for cardiovascular disease, the most common cause of death...
Eligibility Criteria
Inclusion
- Men and women aged 18 to 80 years old
Exclusion
- Have uncontrolled stage 2 hypertension (˃140/90 mmHg)
- Are smokers
- Are pregnant
- Have a history of cardiovascular disease or indication of cardiovascular disease such as myocardial infarction, left ventricular hypertrophy, ischemic heart disease (or prior ischemia), stroke, and/or other vascular disease
- Have a history of lung disease
- Are taking insulin or more than one antihypertensive medication
- Have poorly controlled diabetes: HbA1c levels ˃ 9%
- Have been previously diagnosed with diabetic complications (nephropathy, neuropathy, retinopathy) by their family doctor
Key Trial Info
Start Date :
October 21 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05422430
Start Date
October 21 2021
End Date
April 30 2025
Last Update
March 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Unviersity of Texas at Austin
Austin, Texas, United States, 78712